October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
April 12, 2012 ·
Leave a comment
New press release out today from the offices of Thought Leader Select:
April 12, 2012 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based consulting firm supporting the healthcare industry, is pleased to announce the hiring of Jason Bell as its newest sales executive for the American market.
Bell comes to Thought Leader Select with a solid track record of experience within the biopharmaceutical industry, working as a field hospital representative in support of critical new drug launches in multiple therapeutic areas and disease states, for companies including Allergan, Capellon Pharmaceuticals, and Auriga Pharmaceuticals. In addition to his in-the-field experience and perspective on collaborating with key opinion leaders in medicine to promote effective new treatments, Bell also brings experience gleaned from his time at Clinsys Alterna, a contract research organization (CRO). In his business development role at Clinsys Alterna, Jason consulted with biopharmaceutical industry executives to deliver customized solutions in support of phase I-IV clinical trials.
Jason Bell is a 1997 graduate of California University of Pennsylvania, with a degree in psychology.
“I’m already enjoying my work, speaking with clients and prospective clients about their needs for medical marketing and medical science outreach to health care professionals,” stated Bell. “This company is a great match for my experience and the skills I developed in pharma, CROs, and talent management organizations serving life science ... read more »
March 7, 2012 ·
Leave a comment
Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement a research assessment of key opinion leaders and centers of excellence in the treatment area of women’s health. The company will perform the assessment for a top-50 global biopharmaceutical firm entering the treatment of conditions affecting women.
For the assessment, Thought Leader Select will use its proprietary KOL identification and profiling methodology, known as deep profiling, to pinpoint 100 U. S. key opinion leaders in women’s health, with specialty in the area of obstetrics and gynecology. The company will then study the skills and experience of American OB/GYNs in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.
The client company will utilize Thought Leader Select’s findings to engage key opinion leaders in obstetrics and gynecology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.
In addition to assessing OB/GYN KOLs in the United States, Thought Leader Select will also apply its objective, validated methodology to identify and profile 50 American centers of excellence in the area of women’s health. For the centers of excellence assessment, Thought Leader Select will gauge each center’s community footprint of associated physicians and ... read more »
February 16, 2012 ·
Leave a comment
Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement of a key opinion leader assessment for a top five global pharmaceutical company.
For the assessment, Thought Leader Select will use its proprietary identification methodology to pinpoint 40 Canadian key opinion leaders in oncology, with sub-specialty in the area of skin cancer. The company will study the skills and experience of Canadian oncologists in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.
The client company will utilize Thought Leader Select’s research to engage key opinion leaders in oncology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.
“We are excited about this opportunity to support a great company as they prepare to enter the Canadian market with a new medicine that will improve the lives of patients suffering from skin cancer,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “Our position in the advancement of this new treatment is critical, since our work ensures that the company will be reaching out to the right physicians during the company’s earliest phase of assisting in the treatment of patients in this disease area.”
About Neil Mellor
Neil Mellor is ... read more »
October 14, 2011 ·
Leave a comment
Industry Insights from Paul Meade, M. Sc, MPH
The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical industry? Well, a bit of all three. But it is a bit like the Y2K scare, or the coming of the end of the world in December 2012 predicted by the Mayans—people in healthcare and biopharma are on alert, and no one really knows for certain how this will all play out.
Let’s start with the good, since there will be greater transparency in the interactions between manufacturers and physicians. The intended outcomes will be greater standards of remuneration for services rendered by healthcare professionals to various manufacturers, some defined threshold limit of activities (type and quantity) deemed permissible by institutions for their affiliated physicians, and a greater sense of awareness of the interactions between healthcare professionals and manufacturers, presumably by a concerned public.
With regard to the first outcome, it is hoped that some kind of industry standard for Fair Market Value will be established for the activities physicians are often engaged in when dealing with manufacturers. It will likely serve to “level the playing field,” so some manufacturers will not pay excessively for a given activity, such as consultative services. As ... read more »
March 16, 2011 ·
Leave a comment
March 16, 2011 (CHAPEL HILL, NC)—Research Triangle, NC research and consulting firm Thought Leader Select has initiated a new assessment of medical experts in the field of oncology for the biopharmaceutical industry.
A Canadian subsidiary of a top 10 global biopharmaceutical company has hired the firm to study the skills and experiences of 40 key opinion leaders in the treatment of lung cancer. Thought Leader Select is offering the client company an objective, systematic foundational approach to selecting physicians and other health care professionals within the Canadian care environment to assist the company during its stretch-run of activities in support of the new cancer treatment’s development.
The selected key opinion leaders in Canadian oncology circles will provide a variety of services to the company, including advisory board participation, conducting clinical studies, and offering one-on-one consultations with the company’s scientific and medical teams. Thought Leader Select’s methodology, while compliant with Office of Inspector General guidelines in the United States, is also compliant with Canadian regulations such as the Personal Information Protection and Electronic Documents Act (PIPEDA).
“We have been privileged to work with this company on multiple projects in several therapeutic areas, to ensure that its new product teams are positioned for success by working with the right thought leaders for the right reasons,” stated Neil Mellor, Thought Leader Select’s business development consultant. “This ... read more »
February 22, 2011 ·
Leave a comment
Industry Insights from Paul Meade, M.Sc. MPH
With the Sunshine Act getting closer to implementation, every company that works with thought leaders is preparing for full disclosure and transparency in the way they work and compensate these physicians and other medical experts. So the big question at hand is this–just how many thought leaders should a healthcare manufacturer work with going forward? Some say just a few and others say many. What’s the right answer here?
If we take the argument that working with just a select few is better, one could surmise that it is best to cement a working relationship with a few key thought leaders rather than get to know a “cast of hundreds.” This way, companies may gain a better understanding of the respective key opinion leaders’ interests, preferences, beliefs, and skills. Companies can more effectively create a set of activities that most appropriately matches the skills and experiences of each physician and work with the strengths of each physician to bring new insights into new medical treatment options.
But the one factor working against the “less is more” option is the fact that many academic medical institutions are placing limits on how much remuneration a thought leader can accept from the industry in a given year. Whereas, not too long ago, managed care organizations were placing providers ... read more »
February 14, 2011 ·
Leave a comment
February 14, 2011 (CHAPEL HILL, NC)—Thought Leader Select, a Research Triangle, NC firm focused on collaborations between the biopharmaceutical industry and the medical community, announces the launch of a new media partnership with biopharmaceutical industry blog Marketing4Health.
The research and consulting firm (Thought Leader Select) has signed on to become the blog’s exclusive sponsor, beginning February 14, 2011. With a growing international following and strong readership bases in the United States, Canada, and Europe, Marketing4Health focuses on healthcare and pharmaceutical marketing practices and challenges, as well as emerging trends in technology and social media. Natalie Bourre, the editor of Marketing4Health, is a 13-year industry veteran, with leadership positions at Alcon, Serono, and, most recently at Solvay, where she led the marketing team for Pantoloc (Protonix), which became the 5th largest Rx brand in Canada during her tenure.
“When we were seeking a media partner for 2011, the choice was obvious,” stated Brian Castle, the firm’s director of global marketing and client relations. “Natalie Bourre and Marketing4Health represent a perfect fit for our company, in that she is committed to advising the industry to market new medications in the right ways, whether to medical experts or consumers. With any advertising partnership, we want to drive potential clients our way, and we know that Natalie’s readers are our kind of people—leaders in the industry ... read more »